SEMA3A and tongue cancer: Scores for the NRP1/SEMA3A ratio of ≥1 predicted shorter survival (P=0.045).Conclusions: Aberrant expression of SEMA3A and its receptor NRP1 might be involved in the development of tongue cancer and might be useful prognostic markers in this tumour type.